DZ Bank
RIGL icon

DZ Bank’s Rigel Pharmaceuticals RIGL Stock Holding History

DZ Bank’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,532
Closed -$280K – 1053
2025
Q4 		$280K Sell
6,532
-11,169
-63% -$421K ﹤0.01% 845
2025
Q3 		$501K Buy
17,701
+8,212
+87% +$246K ﹤0.01% 769
2025
Q2 		$178K Buy
+9,489
New +$180K ﹤0.01% 843
2023
Q2 		– Sell
-182,238
Closed -$2.41M – 1089
2023
Q1 		$2.41M Sell
182,238
-38,204
-17% -$607K ﹤0.01% 559
2022
Q4 		$3.31M Buy
220,442
+146,616
+199% +$1.34M 0.01% 506
2022
Q3 		$871K Buy
+73,826
New +$998K ﹤0.01% 699
2018
Q2 		– Sell
-20,000
Closed -$708K – 1048
2018
Q1 		$708K Buy
+20,000
New +$801K ﹤0.01% 728

Other funds holding RIGL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return